According to Perrigo's latest financial reports the company has $0.75 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.75 B | 25.07% |
2022-12-31 | $0.60 B | -67.79% |
2021-12-31 | $1.86 B | 195.31% |
2020-12-31 | $0.63 B | 78.24% |
2019-12-31 | $0.35 B | -35.71% |
2018-12-31 | $0.55 B | -18.8% |
2017-12-31 | $0.67 B | 9.06% |
2016-12-31 | $0.62 B | |
2015-06-30 | $0.78 B | -1.74% |
2014-06-30 | $0.79 B | 2.51% |
2013-06-30 | $0.77 B | 29.44% |
2012-06-30 | $0.60 B | 94.29% |
2011-06-30 | $0.31 B | 181.08% |
2010-06-30 | $0.11 B | -65.1% |
2009-06-30 | $0.31 B | -0.95% |
2008-06-30 | $0.31 B | 301.89% |
2007-06-30 | $79.41 M | 73.58% |
2006-06-30 | $45.75 M | 32.73% |
2005-06-30 | $34.46 M | -79.93% |
2004-06-30 | $0.17 B | 83% |
2003-06-30 | $93.82 M | 22.13% |
2002-06-30 | $76.82 M | 597.39% |
2001-06-30 | $11.01 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $2.99 B | 298.52% | ๐บ๐ธ USA |
Endo International
ENDPQ | $0.77 B | 3.54% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | $0.32 B | -57.05% | ๐บ๐ธ USA |
Catalent CTLT | $0.22 B | -69.52% | ๐บ๐ธ USA |